<DOC>
	<DOCNO>NCT02928679</DOCNO>
	<brief_summary>This substudy randomise trial investigate effect liraglutide body weight pain overweight obese patient knee osteoarthritis ( NCT02905864 ) . In parent trial , patient subject 8-week diet intervention phase include low-calorie diet dietetic counseling , patient randomise receive either liraglutide 3 mg liraglutide 3 mg placebo add-on dietetic guidance re-introducing regular food focus continued motivation engage healthy lifestyle . This substudy aim investigate impact , subsequent change , joint inflammation , articular cartilage composition , overall knee morphology , clinical symptom , obese patient knee osteoarthritis follow randomisation Liraglutide 3 mg Liraglutide 3 mg placebo treatment week 0-52 .</brief_summary>
	<brief_title>Multi-parametric Imaging Knee Obese Patients With Knee Osteoarthritis ; Weight Maintenance</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Same parent trial ( NCT02905864 ) Further Same parent trial ( NCT02905864 ) Usual exclusion criterion MRI ( i.e . pacemaker etc . )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Magnetic resonance imaging</keyword>
	<keyword>Dynamic contrast enhance MRI</keyword>
	<keyword>Liraglutide 3 mg</keyword>
	<keyword>Liraglutide</keyword>
	<keyword>Obesity</keyword>
	<keyword>Osteoarthritis</keyword>
</DOC>